Department of Clinical Sciences Lund, Neurology, Lund University, Lund, Sweden.
J Neurol Neurosurg Psychiatry. 2013 Oct;84(10):1150-5. doi: 10.1136/jnnp-2013-305200. Epub 2013 May 28.
Many studies have focused on short term mortality after primary intracerebral haemorrhage (ICH) whereas long term prognosis and causes of death have been less studied. We therefore examined these issues in a population based cohort of 1 year ICH survivors.
ICH patients in a defined Swedish population (1.14 million inhabitants) were prospectively registered during 1996. Patients surviving 1 year after ICH onset were followed-up regarding survival status and cause of death until December 2009 using data from the National Census Office and the National Cause of Death Register. Patient prognosis was also compared with the general population using official Swedish mortality data. Clinical and radiological prognostic factors were evaluated.
Of 323 patients with ICH, 172 (53%) survived after 1 year, 127 (39%) after 5 years and 57 (18%) after 13 years. Mortality of the 172, 1 year survivors (mean age 67.7 years at ICH) persistently exceeded expected mortality; 13 years post ictus survival was only 34% compared with 61% in the general population. Of 115 deaths among the 172, 1 year survivors, 36% were from cerebrovascular disease and 19% from ischaemic heart disease. Independent risk factors for death among 1 year survivors were age (HR 1.08 per year; 95% CI 1.06 to 1.10; p<0.001), diabetes mellitus at baseline (HR 2.10; 95% CI 1.18 to 3.74; p=0.012) and anticoagulant therapy (HR 1.99; 95% CI 1.12 to 3.53; p=0.018) at ICH onset.
One year survivors after ICH had a substantial and persisting excess mortality compared with the general population. Major causes of death were stroke and ischaemic heart disease.
许多研究都集中在原发性脑出血(ICH)后的短期死亡率上,而长期预后和死亡原因的研究较少。因此,我们在一个 1 年ICH 幸存者的基于人群的队列中研究了这些问题。
在 1996 年期间,在一个确定的瑞典人群(1140 万居民)中前瞻性地登记了 ICH 患者。ICH 发病后存活 1 年的患者通过国家人口普查办公室和国家死因登记处的数据,在 2009 年 12 月之前对其生存状态和死亡原因进行随访。还使用官方瑞典死亡率数据将患者预后与一般人群进行比较。评估了临床和影像学预后因素。
323 名 ICH 患者中,172 名(53%)在 1 年后存活,127 名(39%)在 5 年后存活,57 名(18%)在 13 年后存活。172 名 1 年幸存者(ICH 时平均年龄为 67.7 岁)的死亡率持续超过预期死亡率;发病后 13 年的生存率仅为 34%,而一般人群为 61%。在 172 名 1 年幸存者的 115 例死亡中,36%死于脑血管疾病,19%死于缺血性心脏病。1 年幸存者死亡的独立危险因素为年龄(每增加 1 年 HR 为 1.08;95%CI 为 1.06 至 1.10;p<0.001)、基线时糖尿病(HR 为 2.10;95%CI 为 1.18 至 3.74;p=0.012)和 ICH 发病时抗凝治疗(HR 为 1.99;95%CI 为 1.12 至 3.53;p=0.018)。
与一般人群相比,ICH 后 1 年存活的患者死亡率明显且持续过高。主要死亡原因是中风和缺血性心脏病。